Canopy Growth Corporation Common Shares (CGC) Stock Price

CGCStock

$1.00−45.74%52W

Market Cap$475.32M

P/E—

PEG Ratio—

Div yield—

Beta1.87

CGC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-24.97%

Price vs S&P 500 (4W)6.99%

VGM Score45.23

Book Value / Share (Quarterly)$1.19

P/TBV (Annual)0.99x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-10.94%

Cash Flow / Share (Quarterly)$-0.12

Price vs S&P 500 (YTD)-22.24%

Gross Margin (TTM)27.95%

Net Profit Margin (TTM)-92.38%

EPS (TTM)$-0.59

10-Day Avg Trading Volume0.85M

EPS Excl Extra (TTM)$-0.59

Revenue Growth (5Y)-12.24%

EPS (Annual)$-0.63

ROI (Annual)-27.86%

Gross Margin (Annual)27.95%

Net Profit Margin (5Y Avg)-277.88%

Cash / Share (Quarterly)$0.62

Revenue Growth QoQ (YoY)9.56%

ROA (Last FY)-23.50%

Revenue Growth TTM (YoY)5.80%

EBITD / Share (TTM)$-0.38

ROE (5Y Avg)-139.19%

Operating Margin (TTM)-61.93%

Cash Flow / Share (Annual)$-0.12

P/B Ratio0.91x

P/B Ratio (Quarterly)0.86x

Net Income / Employee (Annual)$-197,167

EV / Revenue (TTM)1.82x

Net Interest Coverage (TTM)-12.06x

ROA (TTM)-25.04%

EV / EBITDA (TTM)112.43x

EPS Incl Extra (Annual)$-0.63

Current Ratio (Annual)3.34x

Quick Ratio (Quarterly)2.60x

3-Month Avg Trading Volume1.44M

52-Week Price Return-45.74%

Revenue / Employee (TTM)$213,436

Tangible BV / Share (Quarterly)$1.03

P/S Ratio (Annual)2.23x

Asset Turnover (Annual)0.25x

52-Week High$2.36

Operating Margin (5Y Avg)-219.98%

EPS Excl Extra (Annual)$-0.63

CapEx CAGR (5Y)-49.09%

Tangible BV CAGR (5Y)-28.75%

26-Week Price Return-13.04%

Quick Ratio (Annual)2.60x

13-Week Price Return-9.09%

Total Debt / Equity (Annual)0.35x

Current Ratio (Quarterly)3.34x

Enterprise Value$372.28M

Revenue / Share Growth (5Y)-8.27%

Asset Turnover (TTM)0.27x

Book Value / Share Growth (5Y)-29.38%

Revenue / Employee (Annual)$213,436

Inventory Turnover (Annual)1.98x

Pretax Margin (Annual)-92.37%

Cash / Share (Annual)$0.62

3-Month Return Std Dev38.09%

Gross Margin (5Y Avg)3.97%

Net Income / Employee (TTM)$-197,167

ROE (Last FY)-37.69%

Net Interest Coverage (Annual)-5.20x

EPS Basic Excl Extra (Annual)$-0.63

Receivables Turnover (TTM)7.23x

Total Debt / Equity (Quarterly)0.35x

EPS Incl Extra (TTM)$-0.59

Receivables Turnover (Annual)7.23x

ROI (TTM)-27.90%

P/S Ratio (TTM)2.23x

Pretax Margin (5Y Avg)-268.23%

Revenue / Share (Annual)$0.69

Tangible BV / Share (Annual)$1.03

Price vs S&P 500 (52W)-64.29%

Year-to-Date Return-10.26%

5-Day Price Return-4.11%

EPS Normalized (Annual)$-0.63

ROA (5Y Avg)-54.45%

Net Profit Margin (Annual)-92.38%

Month-to-Date Return8.53%

Cash Flow / Share (TTM)$-1.31

EBITD / Share (Annual)$-0.38

Operating Margin (Annual)-61.93%

LT Debt / Equity (Annual)0.31x

ROI (5Y Avg)-61.80%

LT Debt / Equity (Quarterly)0.31x

EPS Basic Excl Extra (TTM)$-0.59

P/TBV (Quarterly)0.99x

P/B Ratio (Annual)0.86x

Inventory Turnover (TTM)1.98x

Pretax Margin (TTM)-92.37%

Book Value / Share (Annual)$1.19

Price vs S&P 500 (13W)-11.05%

Beta1.87x

Revenue / Share (TTM)$0.53

ROE (TTM)-39.23%

52-Week Low$0.85

vGradeB

gGradeC

mGradeD

vgmGradeC

CGC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 7, 2026	-$0.02	-$0.01	+43.33%(+$0.01)
Q1 2026	Jun 15, 2026	—	-$0.17	—
Q4 2025	Feb 6, 2026	-$0.04	-$0.10	-183.20%(-$0.06)
Q3 2025	Nov 7, 2025	-$0.08	$0.00	+102.73%(+$0.08)
Q2 2025	Aug 8, 2025	-$0.09	-$0.14	-61.00%(-$0.05)

CGC Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.67

3.75

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
CGCCanopy Growth Corporation Common Shares	B	C	D	$1.00
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$40.98
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	D	$5.50
TRLVTrulieve Cannabis Corp.	B	C	A	$11.82
CRONCronos Group Inc. Common Share	C	B	B	$3.38
GLASGlass House Brands Inc.	C	C	C	$9.88
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.59
SNDLSundial Growers Inc. Common Shares	A	C	D	$1.35
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.29
USNAUSANA Health Sciences Inc	B	D	D	$14.04
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.66
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$9.79
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.57
NAIINatural Alternatives International Inc.	A	C	D	$2.16
MTEXMannatech Inc.	B	D	B	$6.74
BONBon Natural Life Limited Class A Ordinary Shares	B	D	C	$1.14
AKANAkanda Corp. Common Shares	C	F	D	$3.89
IMCCIM Cannabis Corp. Common Shares	A	B	F	$3.41
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
MEHAFunctional Brands, Inc. Common Stock	A	C	D	$0.01
TRUUVanEck Utilities TruSector ETF	—	—	C	$23.37

About Canopy Growth Corporation Common Shares

Canopy Growth is a diversified cannabis producer offering medicinal and recreational products through a portfolio of brands including Doja, LivRelief, Ace Valley, and Deep Space. The company operates across four segments: Canadian cannabis (its primary revenue source), international markets, Storz & Bickel vaporizers, and This Works wellness products.